can tirzepatide cause vision changes Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort TGA Warning: Rare Eye Disorders

Endocrinol ., 32 (4), 285289

, , ,

GLP-1 medications are available at all locations, including telehealth

Hims works well for straightforward prescriptions like finasteride or sildenafil, but its weight-loss and GLP-1 offerings have drawn mixed feedback around provider access, compounding practices, and ongoing support

Glucagon-like Peptide-1 (GLP-1) Agonists Market Summary The GLP-1 agonists market in the 7MM is projected to grow at a significant CAGR by 2036 in leading countries (US, EU4, UK and Japan)

Experts Urge Long-Term Strategies Beyond Medication Based on the findings, the authors conclude: "This evidence cautions against short term use of weight management medications, emphasizes the need for further research into cost effective strategies for long term weight control, and reinforces the importance of primary prevention." A US researcher echoed these concerns in a linked editorial, writing that "The study findings cast doubt on the notion that GLP-1 receptor agonists are a perfect cure for obesity." "People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he adds